Nordic AML Insights – November Update

Explore Nordic AML research covering single-cell and genomic analyses of drug resistance, immune evasion, and disease heterogeneity, alongside population-based studies on rare subtypes, survival outcomes, cardiotoxicity, and long-term effects such as fertility.
Don’t miss these exciting developments!